Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor inde novoacute myeloid leukemia patients-Reference-Cited by-同舟云学术

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor inde novoacute myeloid leukemia patients

Published:2018-05-22 Issue:1 Volume:101 Page:86-94
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Tien Feng-Ming¹²³^ORCID,Hou Hsin-An¹,Tsai Cheng-Hong¹³,Tang Jih-Luh¹³,Chen Chien-Yuan¹,Kuo Yuan-Yeh⁴,Li Chi-Cheng¹³,Lin Chien-Ting¹³,Yao Ming¹,Huang Shang-Yi¹,Ko Bor-Sheng¹,Hsu Szu-Chun⁵,Wu Shang-Ju¹,Tsay Woei¹,Tseng Mei-Hsuan¹,Liu Ming-Chih⁶,Liu Chia-Wen⁶,Lin Liang-In⁷,Chou Wen-Chien¹⁵,Tien Hwei-Fang¹

Affiliation:

1. Department of Internal Medicine; Division of Hematology; National Taiwan University Hospital; Taipei Taiwan

2. Graduate Institute of Clinical Medicine; College of Medicine; National Taiwan University; Taipei Taiwan

3. Tai-Cheng Stem Cell Therapy Center; National Taiwan University; Taipei Taiwan

4. Graduate Institute of Oncology; College of Medicine; National Taiwan University; Taipei Taiwan

5. Department of Laboratory Medicine; National Taiwan University Hospital; Taipei Taiwan

6. Department of Pathology; National Taiwan University Hospital; Taipei Taiwan

7. Department of Clinical Laboratory Sciences and Medical Biotechnology; College of Medicine; National Taiwan University; Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

Ministry of Health and Welfare

National Taiwan University Hospital

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13073/fullpdf

Reference32 articles.

1. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival;Dutcher;J Clin Oncol,1987

2. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate;Porcu;Br J Haematol,1997

3. The role of therapeutic leukapheresis in hyperleukocytotic AML;Pastore;PLoS One,2014

4. How I treat hyperleukocytosis in acute myeloid leukemia;Rollig;Blood,2015

5. Clinical and hematologic characteristics in acute leukemia with 11q23 translocations;Kaneko;Blood,1986

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis;JCO Oncology Practice;2024-07-16

2. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country’s tertiary referral hospital, Ethiopia;BMC Cancer;2024-05-24

3. The Outcome of Patients with Leukemia Presenting with Hyperleukocytosis Requiring Leukapheresis. The Experience of King Fahad Specialist Hospital in Dammam, Saudi Arabia;Journal of Hematology and Clinical Research;2024-03-15

4. Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis;Cancers;2023-12-21

5. Pediatric acute myeloid leukemia and hyperleukocytosis with WBC count greater than 50 × 109/L;International Journal of Hematology;2023-09-21